These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 19098018

  • 1. Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia.
    Koeijvoets KC, Mooijaart SP, Dallinga-Thie GM, Defesche JC, Steyerberg EW, Westendorp RG, Kastelein JJ, van Hagen PM, Sijbrands EJ.
    Eur Heart J; 2009 Mar; 30(5):618-23. PubMed ID: 19098018
    [Abstract] [Full Text] [Related]

  • 2. Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients.
    Buraczynska M, Ksiazek P, Zukowski P, Benedyk-Lorens E, Orlowska-Kowalik G.
    Clin Immunol; 2009 Aug; 132(2):285-90. PubMed ID: 19428307
    [Abstract] [Full Text] [Related]

  • 3. The common Y402H variant in complement factor H gene is not associated with susceptibility to myocardial infarction and its related risk factors.
    Stark K, Neureuther K, Sedlacek K, Hengstenberg W, Fischer M, Baessler A, Wiedmann S, Jeron A, Holmer S, Erdmann J, Schunkert H, Hengstenberg C.
    Clin Sci (Lond); 2007 Aug; 113(4):213-8. PubMed ID: 17472578
    [Abstract] [Full Text] [Related]

  • 4. Complement Factor H polymorphism Y402H associates with inflammation, visual acuity, and cardiovascular mortality in the elderly population at large.
    Mooijaart SP, Koeijvoets KM, Sijbrands EJ, Daha MR, Westendorp RG.
    Exp Gerontol; 2007 Nov; 42(11):1116-22. PubMed ID: 17869048
    [Abstract] [Full Text] [Related]

  • 5. A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study.
    Kardys I, Klaver CC, Despriet DD, Bergen AA, Uitterlinden AG, Hofman A, Oostra BA, Van Duijn CM, de Jong PT, Witteman JC.
    J Am Coll Cardiol; 2006 Apr 18; 47(8):1568-75. PubMed ID: 16630992
    [Abstract] [Full Text] [Related]

  • 6. Analysis of the Y402H variant of the complement factor H gene in age-related macular degeneration.
    Baird PN, Islam FM, Richardson AJ, Cain M, Hunt N, Guymer R.
    Invest Ophthalmol Vis Sci; 2006 Oct 18; 47(10):4194-8. PubMed ID: 17003406
    [Abstract] [Full Text] [Related]

  • 7. TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia.
    Mohrschladt MF, van der Sman-de Beer F, Hofman MK, van der Krabben M, Westendorp RG, Smelt AH.
    Eur J Hum Genet; 2005 Jul 18; 13(7):877-82. PubMed ID: 15856070
    [Abstract] [Full Text] [Related]

  • 8. Genetic determinants of cardiovascular disease risk in familial hypercholesterolemia.
    Jansen AC, van Aalst-Cohen ES, Tanck MW, Cheng S, Fontecha MR, Li J, Defesche JC, Kastelein JJ.
    Arterioscler Thromb Vasc Biol; 2005 Jul 18; 25(7):1475-81. PubMed ID: 15879303
    [Abstract] [Full Text] [Related]

  • 9. Genotype-phenotype correlation of age-related macular degeneration: influence of complement factor H polymorphism.
    Droz I, Mantel I, Ambresin A, Faouzi M, Schorderet DF, Munier FL.
    Br J Ophthalmol; 2008 Apr 18; 92(4):513-7. PubMed ID: 18211923
    [Abstract] [Full Text] [Related]

  • 10. Complement factor H (Y402H) polymorphism and risk of coronary heart disease in US men and women.
    Pai JK, Manson JE, Rexrode KM, Albert CM, Hunter DJ, Rimm EB.
    Eur Heart J; 2007 Jun 18; 28(11):1297-303. PubMed ID: 17483111
    [Abstract] [Full Text] [Related]

  • 11. Usefulness of combining complement factor H and C-reactive protein genetic profiles for predicting myocardial infarction (from the Rotterdam Study).
    Kardys I, de Maat MP, Klaver CC, Despriet DD, Uitterlinden AG, Hofman A, de Jong PT, Witteman JC.
    Am J Cardiol; 2007 Aug 15; 100(4):646-8. PubMed ID: 17697822
    [Abstract] [Full Text] [Related]

  • 12. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients.
    Jansen AC, van Aalst-Cohen ES, Tanck MW, Trip MD, Lansberg PJ, Liem AH, van Lennep HW, Sijbrands EJ, Kastelein JJ.
    J Intern Med; 2004 Dec 15; 256(6):482-90. PubMed ID: 15554949
    [Abstract] [Full Text] [Related]

  • 13. Apolipoprotein E genotype is not associated with cardiovascular disease in heterozygous subjects with familial hypercholesterolemia.
    Mozas P, Castillo S, Reyes G, Tejedor D, Civeira F, García-Alvarez I, Puzo J, Cenarro A, Alonso R, Mata P, Pocoví M, Spanish group FH.
    Am Heart J; 2003 Jun 15; 145(6):999-1005. PubMed ID: 12796755
    [Abstract] [Full Text] [Related]

  • 14. Gene-environment interaction in progression of AMD: the CFH gene, smoking and exposure to chronic infection.
    Baird PN, Robman LD, Richardson AJ, Dimitrov PN, Tikellis G, McCarty CA, Guymer RH.
    Hum Mol Genet; 2008 May 01; 17(9):1299-305. PubMed ID: 18203751
    [Abstract] [Full Text] [Related]

  • 15. Complement receptor 1 gene polymorphism and cardiovascular disease in dialyzed end-stage renal disease patients.
    Buraczynska M, Ksiazek P, Wacinski P, Zukowski P, Dragan M, Bednarek-Skublewska A.
    Hum Immunol; 2010 Sep 01; 71(9):878-82. PubMed ID: 20538029
    [Abstract] [Full Text] [Related]

  • 16. LOC387715/HTRA1 and complement factor H variants in patients with age-related macular degeneration seen at the mayo clinic.
    Pulido JS, Peterson LM, Mutapcic L, Bryant S, Highsmith WE.
    Ophthalmic Genet; 2007 Dec 01; 28(4):203-7. PubMed ID: 18161619
    [Abstract] [Full Text] [Related]

  • 17. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients.
    Buraczynska M, Bednarek-Skublewska A, Buraczynska K, Ksiazek A.
    Cytokine; 2008 Dec 01; 44(3):361-5. PubMed ID: 19014891
    [Abstract] [Full Text] [Related]

  • 18. Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel.
    Chowers I, Cohen Y, Goldenberg-Cohen N, Vicuna-Kojchen J, Lichtinger A, Weinstein O, Pollack A, Axer-Siegel R, Hemo I, Averbukh E, Banin E, Meir T, Lederman M.
    Mol Vis; 2008 Dec 01; 14():1829-34. PubMed ID: 18852870
    [Abstract] [Full Text] [Related]

  • 19. Complement Factor H Y402H polymorphism is associated with an increased risk of mortality after intracerebral hemorrhage.
    Appelboom G, Piazza M, Hwang BY, Bruce S, Smith S, Bratt A, Bagiella E, Badjatia N, Mayer S, Sander Connolly E.
    J Clin Neurosci; 2011 Nov 01; 18(11):1439-43. PubMed ID: 21871809
    [Abstract] [Full Text] [Related]

  • 20. LRP1 gene polymorphisms are associated with premature risk of cardiovascular disease in patients with familial hypercholesterolemia.
    Aledo R, Alonso R, Mata P, Llorente-Cortés V, Padró T, Badimon L.
    Rev Esp Cardiol (Engl Ed); 2012 Sep 01; 65(9):807-12. PubMed ID: 22819221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.